Publique en esta revista
Información de la revista
Vol. 26. Núm. 7.
Páginas 305-316 (Octubre 1990)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 26. Núm. 7.
Páginas 305-316 (Octubre 1990)
DOI: 10.1016/S0300-2896(15)31575-1
Acceso a texto completo
Organización funcional del macrófago alveolar
Visitas
...
J.L. Pérez Arellano, J.E. Losa García, M.J. García Martín, M.C. Alcázar Montero, A. Jiménez López
Servicio de Medicina Interna II, Cátedra de Patología General. Hospital Clínico Universitario Salamanca
M. Cordero Sánchez*
* Servicio de Medicina Interna III. Cátedra de Patología General. Hospital Clínico Universitario Salamanca
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Q.N. Myrvik, E.S. leake, B. Fariss.
Studies on pulmonary alveolar macrophages from the normal rabbit. A technique to procure them in a high State of purity.
J Immunol, 86 (1961), pp. 128-132
[2.]
T.N. Finley, E.W. Swenson, W.S. Curran, G.L. Huber, A.J. Ladman.
Bronchopulmonary lavage in normal subjects and patients with obstructive lung diseases.
Ann Intern Med, 66 (1967), pp. 651-658
[3.]
D.O. Adams, T.A. Hamilton.
The cell biology of macrophage activation.
Ann Rev Immunol, 2 (1984), pp. 283-318
[4.]
M.Y. Gordon.
Adhesive properties of haemopoietic stem cells.
Br J Haematol, 68 (1988), pp. 149-151
[5.]
R.L. Silverstein, R.L. Nachman.
Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion.
J Clin Invest, 79 (1987), pp. 867-874
[6.]
D.R. Phillips, I.F. Charo, L.V. Parise, L.A. Fitzgeral.
The platelet membrane glycoprotein IIb-IIIa complex.
Blood, 71 (1988), pp. 831-843
[7.]
J.F. Bohnsack, H.K. Kleinman, T. Takahashi, J.J. O'Sea, E.J. Brown.
Connective tissue proteins and phagocytic cell function.
Laminin enhances complement and Fc-mediated phagocytosis by cultured human macrophages. J Exp Med, 161 (1985),
[8.]
C.J. Parker, R.N. Frame, M.R. Elstad.
Vitronectin (S protein) augments the functional activity of monocyte receptor for IgG and complement C3b.
Blood, 71 (1988), pp. 86-93
[9.]
J.A. Marino, P.J. Spagnuolo.
Fibronectin and phagocytic clearance mechanisms.
J Lab Clin Med, 111 (1988), pp. 493-494
[10.]
V.M. Holers, T.G. Ruff, D.L. Parks, J.A. McDonald, L.L. Ballard, E.J. Brown.
Molecular cloning of a murine fibronectin receptor and its expression during inflammation.
Expression of VLA-5 is increased in activated peritoneal macrophages in a manner discordant from major histocompatibility complex class II. J Exp Med, 169 (1989), pp. 1589-1605
[11.]
L.M. Shaw, A.M. Mercurio.
Interferon-gamma and lypopolysaccharide promote macrophage adherence to basement membrane glycoproteins.
J Exp Med, 1169 (1989), pp. 303-308
[12.]
E.J. Brown, J.L. Goodwin.
Fibronectin receptors of phagocytes.
Characterization of the Arg-Gly-Asp binding proteins of human monocytes and polymorphonuclear leukocytes. J Exp Med, 167 (1988), pp. 777-793
[13.]
P.W. Modderman, A.E.G. Von der Borne, A. Sonnenberg.
VLA-2, VLA-5.
VLA-6 function as activation-independent platelet adhesion receptors for collagen, fibronectin and laminin respectively. Tissue Antigens, 33 (1989), pp. 357
[14.]
B. Villiger, D.G. Kelley, W. Engleman, C. Kuhn, J.A. McDonald.
Human alveolar macrophage fibronectin: synthesis secretion ultrastructural localization during gelatin-coated latex particle binding.
J. Cell Biol, 90 (1981), pp. 711-720
[15.]
H. Hand, A. Thori, J. Schlom, C.N. Rao, L. Liotta.
Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody.
Cancer Res, 45 (1985), pp. 2713-2719
[16.]
S. Bhakdi, R. Kaflein, T.S. Halstensen, F. Hugo, K.T. Preissner, T.E. Mollnes.
Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
Clin Exp Immunol, 74 (1988), pp. 459-464
[17.]
S.M. Nesbitt, I. Hart, M.A. Horton.
Epitope analysis of the vitronectin receptor α and ß chains.
Tissue Antigens, 33 (1989), pp. 357
[18.]
R.L.H. Bolhuis, P. Goedegebuure, D.M. Segal, S. Shaw, E. Braakman.
LFA-1 represents an adhesion molecule interacting with ICAM1.
Tissue Antigens, 33 (1989), pp. 253
[19.]
D.R. Freyer, M.L. Morganroth, C.E. Rogers, M.A. Arnaout, R.F. Todd.
Modulation of surface CD11/CD18 glycoproteins (Mol.
LFA-1, pl50,95) by human mononuclear phagocytes. Clin Immunol Immunopathol, 46 (1988), pp. 272-283
[20.]
S. Kouzan, R.D. Nolan, T. Fournier, J. Bignon, T.E. Eling, A.R. Brody.
Stimulation of arachidonic acid metabolism by adherence of alveolar macrophages to a plastic substrate.
Modulation by fetal bovine serum. Am Rev Respir Dis, 137 (1988), pp. 38-43
[21.]
C.M. Smith, D.P. Tukey, D. Mundshenk, et al.
Filtration deformability of rabbit pulmonary macrophage.
J Lab Clin Med, 99 (1982), pp. 568-579
[22.]
K.A. Brown, J. Ferrie, B. Wilbourn, D.C. Dumonde.
Benoxaprofen a potent inhibitor of monocyte/endothelial-cell interaction.
Lancet, 2 (1984), pp. 643
[23.]
D. Rimland, W.L. Hand.
The effect of ethanol on adherence and phagocytosis by rabbit alveolar macrophages.
J Lab Clin Med, 95 (1980), pp. 918-926
[24.]
R. Lomnitzer, A.R. Rabson, H.J. Koornhof.
The effects of cyclic AMP on leukocyte inhibitory factor production and on the inhibition of leukocyte migration.
Clin Exp Immunol, 24 (1976), pp. 42-48
[25.]
L.A. Boxer, J.M. Allen, A.M. Watanabe, et al.
Role of microtubules in granulocyte adherence.
Blood, 51 (1978), pp. 1045-1049
[26.]
R. McGregor, H. Friedman, E. Macarak, N. Kefalides.
Virus infection of endothelial cells increased granullocyte adherence.
J Clin Invest, 65 (1980), pp. 1469-1477
[27.]
C. Bowman, E. Butler, J. Repine.
Hyperoxia damages cultured endothedial cells causing increased neutrophil adherence.
Am Rev Respir Dis, 128 (1983), pp. 469-472
[28.]
W.J. Martin.
Endothelial-leukocyte adhesiveness.
J Lab Clin Med, 111 (1988), pp. 265-266
[29.]
U. Ryan, D. Schultz, J. Ryan.
Fc and C3 receptors on pulmonary endothelial cells.
Induction by injury. Science, 214 (1981), pp. 557-558
[30.]
V. Rossi, F. Breviario, P. Ghezzi, E. Dejana, A. Mantovani.
Prostacyclin synthesis induced in vascular cells by interleukin-1.
Science, 229 (1985), pp. 174-176
[31.]
M.P. Bevilacqua, J.S. Pobers, W. Majeau Fiers, R.S. Cotran, M.A. Gimbrone.
Recombinant tumor necrosis factor induced procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin-1.
Proc Natl Acad Sci USA, 83 (1986), pp. 4533-4537
[32.]
A.W. Boyd, I.P. Wicks, S.O. Wawrik, et al.
Functional studies on intercellular adhesions molecule-1 (ICAM-1).
Tissue Antigens, 33 (1989), pp. 279
[33.]
D.E. Doherty, C. Haslett, M.G. Tonnesen, P.M. Henson.
Human monocyte adherence: A primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
J Immunol, 138 (1987), pp. 1762-1771
[34.]
G. Endermann, A. Pronzcuk, G. Friedman, S. Lyndsey, L. Alderson, K.C. Hayes.
Monocyte adherence to endothelial cells in vitro is increased by beta-VLDL.
Am J Pathol, 126 (1987), pp. 1-6
[35.]
R.B. Fick, E.S. Paul, W.W. Merrill, H.Y. Reynolds, J.S.O. Loke.
Alterations in the antibacterial properties of rabbit pulmonary macrophages exposed to wood smoke.
Am Rev Respir Dis, 129 (1984), pp. 76-81
[36.]
J.L. Pérez Castrillon, J.D. García Palomo, J.L. Pérez Arellano, A. Jiménez López.
Leukocyte chemotaxis.
Allergol et Immunopathol, 16 (1988), pp. 279-283
[37.]
R. Snyderman, M.C. Pike.
Chemoattractant receptors on phagocytic cells.
Ann Rev Immunol, 2 (1984), pp. 257-281
[38.]
M.R. Ruff, S.M. Wahl, C.B. Pert, P. Substance.
receptor-mediated chemotaxis of human monocytes.
Peptides, 6 (1985), pp. 107-111
[39.]
L.G. Miller, S. Nelson, W.R. Summer.
Benzodiacepine bindings sites on rat alveolar macrophages promote chemoluminiscence and chemotaxis.
Am Rev Respir Dis, 137 (1988), pp. A528
[40.]
I.M. Goldstein.
Chemotactic factor receptors on leukocytesscrantching the surface.
J Lab Clin Med, 97 (1981), pp. 599-601
[41.]
J. Moss, M. Vaughan.
Guanine nucleotide-binding proteins (G proteins) in activation of adenyl cyclase: Lessons learned from cholera and travelers diarrhea.
J Lab Clin Med, 113 (1989), pp. 258-268
[42.]
R.H. Michell.
How do receptors at the cell surface send signals to the cell interior.
Br Med J, 295 (1987), pp. 1320-1323
[43.]
R.H. Michell.
Post-receptor signalling pathways.
[44.]
T.P. Stossel.
The mechanical responses of white blood cells.
Inflammation: Basic principles and clinical correlates, pp. 325-342
[45.]
G. Poli, A. Erroi, N. Polentarutti, et al.
Defective chemotaxis of human alveolar macrophages.
Clin Immunol Immunopathol, 47 (1988), pp. 282-288
[46.]
E.L. Becker.
Chemotaxis.
J Allergy Clin Immunol, 66 (1980), pp. 97-105
[47.]
G.A. Warr, R.R. Martin.
Chemotactic responsiveness of human alveolar macrophages: effects of cigarette smoking.
Infect Immun, 9 (1974), pp. 769-771
[48.]
G.A. Warr, R.R. Mmartin.
In vitro migration of human alveolar macrophages.
Effects of cigarette smoking. Infect Immunol, 8 (1973), pp. 222-227
[49.]
G.B. Demarest, L.D. Hudson, L.C. Altman.
Impaired alveolar macrophage chemotaxis in patients with acute smoke inhalation.
Am Rev Respir Dis, 119 (1979), pp. 279-286
[50.]
C. Burgaleta, M.T. Moreno, J.L. de la Cruz.
Actividad funcional de los macrófagos alveolares en patología intersticial pulmonar.
Med Clin (Barc), 90 (1988), pp. 321-324
[51.]
E. Lemaire, P. Care, M.F. Legrand, et al.
Alveolar macrophage dysfunction in malignant lung tumours.
Thorax, 39 (1984), pp. 448-452
[52.]
R.A. Robbins, J.K. Rasmussen, M.E. Clayton, G.L. Gossman, T.J. Kendall, S.I. Rennard.
Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
J Lab Clin Med, 110 (1987), pp. 292-299
[53.]
G.P. Pasternack, R. Snyderman, M.C. Pike, R.J. Johnson, H.S. Shin.
Resistance of neoplasm to immunological destruction: role of a macrophage chemotaxis inhibitor.
J Exp Med, 149 (1978), pp. 93-102
[54.]
J. Muller-Quernheim, R.E. Schopf, P. Benes, V. Schultz, R. Ferlinz.
A macrophage-suppressing 40-kD protein in a case of pulmonary alveolar proteinosis.
Klin Wochenschr, 65 (1987), pp. 893-897
[55.]
J.E. Glasgow, B.E. Farrell, E.S. Fisher, D.A. Lauffenburger, R.P. Daniele.
The motile response of alveolar macrophages.
An experimental study using single cell and cell population approaches. Am Rev Respir Dis, 139 (1989), pp. 320-339
[56.]
R.N. Harada, J.E. Repine.
Pulmonary host defense mechanisms.
Chest, 87 (1985), pp. 247-252
[57.]
N.P. Christiansen, K.M. Skubitz.
Identification of the major lectin-binding surface proteins of human neutrophils and alveolar macrophages.
Blood, 71 (1988), pp. 1624-1632
[58.]
M. Kuhlman, K. Joiner, R.A.B. Ezekowitz.
The human mannosebinding protein functions as an opsonin.
J Exp Med, 169 (1989), pp. 173-1745
[59.]
A.B. Ezekowitz, L.E. Day, G.A. Herman.
A human mannosebinding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins.
J Exp Med, 167 (1988), pp. 1034-1046
[60.]
S.D. Wright, S.M. Levin, M.T.C. Jong, Z. Chad, L.G. Kabbash.
CD3(Cd l lb/CD18) expresses one bindings site for Arg-Gly-AspContaining peptides and a second site for bacterial lypopolysaccharide.
J Exp Med, 169 (1989), pp. 175-183
[61.]
H.M. Wolf, J.W. Mannhalter, H.C. Salzmann, J. Gottlicher, R. Ahmad, M.M. Eibl.
Phagocytosis of serum-opsonized symosan downregulares the expression of CR3 and FCRI in the membranes of human monocytes.
J Immunol, 141 (1988), pp. 3537-3543
[62.]
A. Ding, S.D. Weight, C. Nathan.
Activation of mouse peritoneal macrophages by monoclonal antibodies to Mac 1 (Complement receptor type 3).
J Exp Med, 165 (1987), pp. 733-749
[63.]
B.I. Myones, J.G. Dalzell, N. Hogg, G.D. Ross.
Neutrophil and monocyte cell surface p 150,95 has iC3b-receptor (CR4) activity resembling CR3.
J Clin Invest, 82 (1988), pp. 640-651
[64.]
J.C. Unkeless.
Function and heterogeneity of human Fc receptors for immunoglobulin G.
J Clin Invest, 83 (1989), pp. 355-361
[65.]
S.B. Clarkson, P.A. Ory.
CD16. Developmentally regulated IgG Fe receptors on cultured human monocytes.
J Exp Med, 167 (1988), pp. 408-417
[66.]
E.J. Brown, A.M. Newell, H.D. Gresham.
Molecular regulation of phagocyte function.
Evidence for involvement of a guanosinetriphosphate-binding protein in opsonin-mediated phagocytosis by monocytes. J Immunol, 139 (1987), pp. 3777-3782
[67.]
S. Kouzan, J.E. Gallagher, T. Eling, A.R. Brody.
Binding of iron beads to sialic acid residues on macrophage membranes stimulates arachidonic acid metabolism.
Lab Invest, 53 (1985), pp. 320-327
[68.]
T.P. Stossel, J.H. Hartwig.
Interactions of actin, myosin, and a new actin-binding protein of rabbit pulmonary macrophages II.
Role in cytoplasmic movement and phagocytosis. J Cell Biol, 68 (1976), pp. 602-619
[69.]
J.H. Hartwig, W.A. Davies, T.P. Stossel.
Evidence for contractile protein translocation in macrophage spreading, phagocytosis, and phagolysosome formation.
J Cell Biol, 75 (1977), pp. 956-967
[70.]
P. D’Arcy Hart, M.R. Young, A.H. Gordon, K.H. Sullivan.
Inhibition of phagosome-lysosome fusion in macrophages by certain mycobacteria can be explained by inhibition of lysosomal movements observed after phagocytosis.
J Exp Med, 166 (1987), pp. 933-946
[71.]
R.J. Mason, T.P. Stossel, M. Vaughan.
Quantitative studies of phagocytosis by alveolar macrophages.
Biochem Biophys Acta, 304 (1973), pp. 864-870
[72.]
A.L. Esposito, L.A. Quinn, E.C. Lucey, G.L. Snider.
Effect of the elastase inhibitor.
Eglin-c on antibacterial mechanisms in experimental pneumonia. Description of a system to quantitative phagocytic and bactericidal activity of resident murine alveolar macrophages in vivo. Am Rev Respir Dis, 135 (1987), pp. 676-681
[73.]
S.J. Klebanoff.
Phagocytic cells: Products of oxygen memtabolism.
Inflammation. Basic principies and clinical correlates, pp. 391-444
[74.]
M.S. Cohen, B.E. Britigan, D.J. Hassett, G.M. Rosen.
Phagocytes.
O2 reduction and hydroxyl radical. Rev Infect Dis, 10 (1988), pp. 1088-1096
[75.]
A. Cantin, R. Begin.
Inorganic dust exposure enhances PMAstimulated alveolar macrophage superoxide release.
Am Rev Respir Dis, 135 (1987), pp. A346
[76.]
J.E. Craighead, B.T. Mossman.
The pathogenesis of asbestosassociated diseases.
N Engl J Med, 305 (1982), pp. 1446-1455
[77.]
E. Kagan, Y. Oghiso, D.P. Hartmann.
Enhanced release of a chemoattractant for alveolar macrophages after asbestos inhalation.
Am Rev Respir Dis, 128 (1983), pp. 680-687
[78.]
E.M. Lugano, J.H. Dauber, R.P. Daniele.
Acute experimental silicosis.
Lung morphology, histology and macrophage chemotaxin secretion. Am J Pathol, 109 (1982), pp. 27-36
[79.]
W.N. Rom, P.B. Bitterman, S.I. Rennard, A. Cantin, R.G. Crystal.
Characterization of the lower respiratory tract inflammation of non smoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts.
Am Rev Respir Dis, 136 (1987), pp. 1429-1434
[80.]
E. Goldstein, W. Lippert, D. Warhauer.
Pulmonary alveolar macrophage.
Defender against bacterial infection of the lung. J Clin Invest, 54 (1974), pp. 519-528
[81.]
S. Johnsson, D.M. Nusher, A. Chapman, A. Goree, E.C. Lawrence.
Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages.
J Infect Dis, 152 (1985), pp. 4-13
[82.]
S. Johnsson, D.M. Musher, E.C. Lawrence.
Phagocytosis and killing of Haemophilus influenzae by alveolar macrophages.
No difference between smokers and non-smokers. Eur J Respir Dis, 70 (1987), pp. 309-315
[83.]
G.M. Green, E.H. Kass.
The role of the alveolar macrophage in the clearance of bacteria from the lung.
J Exp Med, 119 (1964), pp. 167-175
[84.]
H.Y. Reynolds, J.A. Hazmierowski, H.H. Newball.
Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.
J Clin Invest, 56 (1975), pp. 376-385
[85.]
T.F. Byrd, M.A. Horwitz.
Interferon gamma-activated human monocytes down-regulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophilia by limiting the availability of iron.
J Clin Invest, 83 (1989), pp. 1457-1465
[86.]
M. Kist, H. Koester, W. Bredt.
Mycoplasma pneumonia induced cytotoxic activity in guinea pig bronchoalveolar cell.
Am Rev Respir Dis, 131 (1985), pp. 869-874
[87.]
P.R.J. Gangadharam, P.F. Pratt.
In vitro response of murine alveolar and peritoneal macrophages to Mycobacterium intracellulare.
Am Rev Respir Dis, 128 (1983), pp. 1044-1047
[88.]
P.B. Weimberg, S. Becker, D.L. Granger, H.S. Koren.
Growth inhibition of Cryptococcus neoformans by human alveolar macrophages.
Am Rev Respir Dis, 136 (1987), pp. 1242-1247
[89.]
L. Beaman.
Fungicidal activation of murine macrophages by recombinant gamma interferon.
Infect Immun, 55 (1987), pp. 2951-2955
[90.]
E.J. Stott, M. Probert, L.H. Thomas.
Cytotoxicity of alveolar macrophages for virus-infected cells.
Nature, 255 (1975), pp. 710-712
[91.]
P.D. Walzer, M.E. Rutledge.
Humoral immunity in experimental Pneumocystis carinii infection.
J Lab Clin Med, 97 (1981), pp. 820-833
[92.]
J.M. Onofrio, G.B. Toews, M.F. Lipscomb, A.K. Pierce.
Granulocyte-alveolar-macrophage interaction in the pulmonary clearance of Staphylococcus aureus.
Am Rev Respir Dis, 127 (1983), pp. 335-3341
[93.]
E. Brummer, D.A. Stevens.
Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines.
Clin Exp Immunol, 70 (1987), pp. 520-528
[94.]
D.O. Adams, T.A. Hamilton.
Phagocytic cells: cytotoxic activities of macrophages.
Infflammation: Basic principies and clinical correlates, pp. 471-492
[95.]
P.C. Levy, R.J. Looney, N.J. Roberts, M.W. Frampton, D.H. Ryan, M.J. Utell.
Human alveolar macrophage antibody dependent cellularcytotoxicity (ADCC): Fc-gamma receptor I (FCRI) dependence and inhibition by human surfactant.
Am Rev Respir Dis, 137 (1988), pp. A39
[96.]
C. Bordignon, R. Avallone, G. Peri, N. Polentarutti, C. Mangioni, A. Mantovani.
Cytotoxicity on tumor cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.
Clin Exp Immunol, 41 (1980), pp. 336-342
[97.]
J.C. Wissler, M.F. Lipscomb, V.M. Lem, G.B. Toews.
Tumor killing by human alveolar macrophages and blood monocytes.
Decreased cytotoxicity of human alveolar macrophages. Am Rev Respir Dis, 134 (1986), pp. 5332-5537
[98.]
S. Sone, S. Moriguchi, E. Shimizu, F. Ogushi, E. Tsubara.
In vitro generation of tumoricidal properties in human alveolar macrophages following interaction with endotoxin.
Cancer Res, 42 (1982), pp. 2227-2231
[99.]
P. LeMarbre, R. Vessella, J. Hoidal, J. Rinehart.
Human pulmonary macrophage tumor cell cytotoxicity.
Blood, 55 (1980), pp. 612-617
[100.]
W.B. Davis, E.R. Pacht, M. Spatafora, W.J. Martin.
Enhanced cytotoxic potential of alveolar macrophages from cigarette smokers.
J Lab Clin Med, 111 (1988), pp. 293-298
[101.]
R.T. Perri, G. Vercellotti, J. McCarthy, R.L. Vessella, L.T. Furcht.
Laminin selectively enhances monocyte-macrophage tumoricidal activity.
J Lab Clin Med, 105 (1985), pp. 30-35
[102.]
D.B. Ettensohn, P.A. Lalor, N.J. Roberts.
Human alveolar macrophage suppression of lymphocyte proliferation.
Am Rev Respir Dis, 137 (1988), pp. 765-773
[103.]
P.G. Holt.
Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages.
Clin Exp Immunol, 63 (1986), pp. 261-270
[104.]
G.W. Hunninghake.
Immunoregulatory functions of human alveolar macrophages.
Am Rev Respir Dis, 136 (1987), pp. 258-265
[105.]
H.B. Kaltreider, macrophages. Alveolar.
Enhancers or suppressors of pulmonary immune reactivity?.
Chest, 82 (1982), pp. 261-262
[106.]
E.A. Rich, D.J. Tweardy, H. Fugiwara, J.J. Ellner.
Spectrum of immunoregulatory functions and properties of human alveolar macrophages.
Am Rev Respir Dis, 136 (1987), pp. 258-265
[107.]
A. Lasser.
The mononuclear phagocytic system. A review.
Hum Pathol, 14 (1983), pp. 108-126
[108.]
Z.A. Ccohn.
The activation of mononuclear phagocytes: fact, fancy and future.
J Immunol, (1978), pp. 813-816
[109.]
W.P. Arend, M. Mannik.
The macrophage receptor for IgG: number and affinity for bindings sites.
J Immunol, 110 (1973), pp. 1455-1463
[110.]
J.D. Brain.
Lung macrophages.
How many kinds are there?. What do they do?. Am Rev Respir Dis, 137 (1988), pp. 507-509
[111.]
J.C. Weissler, R. Lyons, M.F. Lipscomb, G.B. Toews.
Human pulmonary macrophages.
Functional comparison of cells obtained from whole lung and by bronchoalveolar lavage. Am Rev Respir Dis, 133 (1986), pp. 437-477
[112.]
M.D. Rossman, S.D. Douglas.
The alveolar macrophage: Receptors and effector cell function.
Immunology and immunologic diseases of the lung, pp. 168-183
[113.]
A.B. Cohen, M.J. Cline.
The human alveolar macrophage: Isolation, cultivation in vitro, and studies of morphologic and functional characteristics.
J Clin Invest, 50 (1971), pp. 1390-1398
[114.]
P.E.G. Mann, A.B. Cohen, T.N. Finley, A.J. Ladman.
Alveolar macrophages. Structural and functional differences between nonsmokers and smokers of marijuana and tobacco.
Lab Invest, 25 (1971), pp. 111-120
[115.]
F. Jauvert, J. Bignon, P. Sebastien, P. Butez.
Stereological study of mononuclear alveolar cells collected by alveolar lavage in man.
Rev Fran Mal Resp, 2 (1974), pp. 18-27
[116.]
D. Sandron, H.Y. Reynolds, A.M. Laval, A. Venet, D. Israel--Biet, J. Chrétien.
Human alveolar macrophage subpopulations isolated on discontinuous albumin gradients.
Cytological data in normals and sarcoid patients. Eur J Respir Dis, 68 (1986), pp. 177-185
[117.]
J.A. Elias, A.D. Schreiber, K. Gustilo, et al.
Differential inerleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes.
Relationship to cell maturity. J Immunol, 135 (1985), pp. 3198-3200
[118.]
V.A. Grant, A.S. Hamblin.
Human bronchoalveolar macrophage heterogeneity demonstrated by histochemistry, surface markers and phagocytosis.
Clin Exp Immunol, 60 (1985), pp. 539-545
[119.]
J.A. Elias, M.D. Rossman, R.B. Zurier, R.P. Daniele.
Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin dependent process.
Am Rev Respir Dis, 131 (1985), pp. 94-99
[120.]
D. Sandron, H.Y. Reynoilds, A. Venet, A.M. Laval, D. Israel-Biet, J. Chrétien.
Human alveolar macrophage subpopulations isolated on discontinuous albumin gradients: functional data in normal and sarcoid patients.
Eur J Respir Dis, 69 (1986), pp. 226-234
[121.]
T.J. Ferro, J.A. Kern, J.A. Elias, M. Kamoun, R.P. Daniele, M.D. Rossman.
Alveolar macrophages, blood monocytes and densityfractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen.
Am Rev Respir Dis, 135 (1987), pp. 682-687
[122.]
N. Clerici, S. Reboiras, C. Fierro, F. Leyva-Cobian.
Expression of la like (HLA-DR) antigens on human alveolar macrophages.
Clin Exp Immunol, 58 (1984), pp. 388-394
[123.]
A. Razma, J. Lynch, B. Wilson, P. Ward, S. Kunkel.
Expression of Ia-like (DR) antigen on human alveolar macrophages isolated by bronchoalveolar lavage.
Am Rev Respir Dis, 129 (1984), pp. 419-424
[124.]
U. Costabel, K.J. Bross, R. Andreesen, H. Mathys.
HLA-DR antigens on human macrophages from bronchoalveolar lavage fluid.
Thorax, 41 (1986), pp. 261-265
[125.]
M.F. Lipscomb, C.R. Lyons, G. Nuñez, et al.
Human alveolar macrophages synthetise HLA-DR antigens in culture.
Am Rev. Respir Dis, 127 (1983), pp. A59
[126.]
J.S. Maron, L.C. Watters, T.E. King, R.J. Mason.
Alveolar macrophage HLA-DR expression is reduced in patients with idiopathic pulmonary fibrosis compared to healthy volunteers and correlates with T lymphocyte helper/suppreessor ratio.
Am Rev Respir Dis, 133 (1986), pp. A146
[127.]
D.A. Campbell, R.M. du Bois, R.G. Butcher, L.W. Poulter.
The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.
Clin Exp Immunol, 65 (1986), pp. 165-171
[128.]
D. Fertsch-Ruggio, D.R. Schoenberg, K. Vogel.
Induction of macrophage la antigen expression by rIFN-gamma and downregulation by IFN-alpha/beta and dexametasone are regulated transcriptionally.
J Immunol, 141 (1988), pp. 1582-1589
[129.]
L.A. Falk, L.M. Wahl, S.N. Vogel.
Analysis of la antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony stimulating factor or macrophage colony stimulating factor.
J Immunol, 140 (1988), pp. 2652-2660
[130.]
H.G. Fischer, S. Frosch, K. Reske, A.B. Reske-Kunz.
Granulocyte-macrophage colony-stimulating factors activates macrophage derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
J Immunol, 141 (1988), pp. 3882-3888
[131.]
T.J. Koerner, T.A. Hamilton, D.O. Adams.
Suppressed expression of surface la on macrophages by lipopolysaccharide: Evidence. for regulation at the level of accumulation of mRNA.
J Immunol, 139 (1987), pp. 239-243
[132.]
H.B. Kaltreider, P.K. Byrd, J.L. Curtis.
Expression of la by murine alveolar macrophages is up-regulated during the evolution of a specific immune response in pulmonary parenchyma.
Am Rev Respir Dis, 137 (1988), pp. 1411-1416
[133.]
M.F. Lipscomb, C.R. Lyons, G. Nuñez, et al.
Human alveolar macrophages: HLA-DR positive macrophages that are poor stimulators of a primary mixed leukocyte reaction.
J Immunol, 136 (1986), pp. 497-504
[134.]
T.J. Ferro, D.S. Monos, B.T. Spear, et al.
Carbohydrate differences in HLA-DR molecules synthesized by alveolar macrophages and blood monocytes.
Am Rev Respir Dis, 135 (1987), pp. 1340-1344
[135.]
G.B. Toews, W.C. Vial, M.M. Dunn, M.F. Lipscomb.
Human alveolar macrophages produce interleukin-1.
Am Rev Respir Dis, 127 (1983), pp. A60
[136.]
M. Wewers, P. Bitterman, P. Pinkston, R.G. Crystal.
Human alveolar macrophages release much less interleukin-1 than human blood monocytes.
Am Rev Respir Dis, 127 (1983), pp. A59
[137.]
G.A. Koretzky, J.A. Elias, S.L. Kay, M.D. Rossman, P.C. Nowell, R.P. Daniele.
Spontaneous production of interleukin-1 by human alveolar macrophages.
Clin Immunol Immunopathol, 29 (1983), pp. 443-450
[138.]
S. Nagai, M. Takeuchi, K. Watanabe, H. Aung, T. Izumi.
Smoking and interleukin-1 activity released from human alveolar macrophages in healthy subjects.
Chest, 94 (1988), pp. 694-700
[139.]
G.P. Brown, M. Monick, G.W. Hunninghake.
Interleukin-1 release is decreased from alveolar macrophages of smokers.
Am Rev Respir Dis, 137 (1988), pp. A88
[140.]
M.D. Wewers, C. Saltini, S. Sellers, et al.
Evaluation of alveolar macrophages in normals and individuals with active pulmonary sarcoidosis for the spontaneous expression of the interleukin-1 βgene.
Cell Immunol, 107 (1987), pp. 479-488
[141.]
G.W. Hunninghake.
Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
Am Rev Respir Dis, 129 (1984), pp. 569-572
[142.]
J.A. Kern, R.J. Lamb, J.C. Reed, J.A. Elias, R.P. Daniele.
Interleukin-1 beta gene expression in human monocytes and alveolar macrophages from normal subjects and patients with sarcoidosis.
Am Rev Respir Dis, 137 (1988), pp. 1180-1184
[143.]
Endres S, Ghorbani R, Lonnemann G, Van der Meer JWM, Dinarello CA. Measurement of immunoreactive interleukin 1 ß from human mononuclear cells: Optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor.
[144.]
S. Nagai, M. Takeuchi, T. Izumi.
The significance of IL-1 and the IL-1 inhibitory factor in the evaluation of inflammatory State in sarcoidosis and idiopathic pulmonary fibrosis.
Am Rev Respir Dis, 135 (1987), pp. A305
[145.]
P. Gosset, P. Lassalle, A.B. Tonnel, et al.
Production of an interleukin-1 inhibitory factor by human alveolar macrophages from normals and allergic asthmatic patients.
Am Rev Respir Dis, 138 (1988), pp. 40-46
[146.]
N.J. Roberts, A.H. Prill, T.N. Mann.
Interleukin-1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus.
J Exp Med, 163 (1986), pp. 511-519
[147.]
M. Monick, J. Glazier, G.W. Hunninghake.
Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2.
Am Rev Respir Dis, 135 (1987), pp. 72-77
Copyright © 1990. Sociedad Española de Neumología y Cirugía Torácica
Idiomas
Archivos de Bronconeumología

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?